Pavilion Health Today
Supporting healthcare professionals to deliver the best patient care

Search & Filter

Enter one or more words in to the search box and press Enter.
With each additional filter selection requires the articles to have each of the categories selected.

  • Filter by Section

  • Filter by Author

Trial shows that afatinib is superior in reducing the risk of lung cancer progression

October 6, 2022
Alison Bloomer
The results of a new lung cancer trial have demonstrated that afatinib is superior in reducing the risk of lung cancer progression to gefitinib.

NICE issues guidance for olaparib in ovarian cancer

October 6, 2022
Alison Bloomer
NICE has issued Technology Appraisal Guidance (TAG) for olaparib (Lynparza) for treatment of high-grade serous ovarian cancer.

Screening age too high for many diagnosed with colorectal cancer

October 6, 2022
Alison Bloomer
Many young people are missing out on vital screening for colorectal cancer because they're not over 50 years of age, meaning they often present at advanced stages of the disease.

Patients in Leeds to benefit from new pain management app

October 6, 2022
admin
More than 7,000 patients in the Leeds area who are living with chronic pain will have access to a new pain management app.

Man dies in France after clinical drug trial

October 6, 2022
admin
The trial, which focused on a new oral drug, has since been suspended.

Alzheimer’s drug prescriptions six times higher than decade ago, new figures show

October 6, 2022
admin
The number of prescriptions dispensed in England for approved medicines to treat Alzheimer's disease increased from 502,000 in 2004 to 3 million in 2014.

Oral nutritional supplement drink is associated with 50% lower death rate in older malnourished patients

October 6, 2022
admin
Results from a new clinical trial show that the use of a specialised nutritional supplement drink was associated with a 50% lower death rate in older malnourished patients with a heart or lung disease 90 days following hospitalisation.

Shocking variation of hospital care for people with dementia exposed

October 6, 2022
admin
An investigation from the Alzheimer's Society has found that many people with dementia are falling while in hospital, being discharged at night or being marooned in hospital despite their medical treatment having finished.

Arthritis drug could help combat ovarian cancer

October 6, 2022
admin
An arthritis drug could potentially improve the prognosis for ovarian cancer patients with a faulty BRCA1 gene.

New results from major national survey looks for the first time at mental health experiences of over 5,000 adults

October 6, 2022
admin
One in four adults (26%) surveyed as part of the Health Survey for England (HSE) said they had been diagnosed with a mental illness at some point in their lifetime according to the Health and Social Care Information Centre (HSCIC).

Glycemic awareness lower among older adults with type 1 diabetes

October 6, 2022
admin
Older adults with long-standing type 1 diabetes are more likely to experience a severe hypoglycemic episode with greater hypoglycemia unawareness and glucose variability, according to study findings.

New haemophilia A treatment offers prolonged protection against bleeding episodes

October 6, 2022
admin
Sobi has announced the UK launch of Elocta, a haemophilia A treatment that offers prolonged protection against bleeding episodes.

New guidelines on anti-rheumatic drugs in pregnancy launched

October 6, 2022
admin
The British Society for Rheumatology (BSR) has published new guidelines on prescribing anti-rheumatic drugs in pregnancy.

Research suggests diabetes risk from potato-rich diet

October 6, 2022
admin
Starch in potatoes can trigger a sharp rise in blood sugar levels leading to an increased risk of diabetes during pregnancy according to new US research.

Researchers uncover weakness in leukaemia cells

October 6, 2022
admin
UK scientists have helped show that a pair of genes inside cells could play a major role in how a serious form of leukaemia develops.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more ...

Privacy & Cookies Policy